Torti Frank (CIK 1647805) reported 15 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell ROIV (40,310 shares), Buy IMVT (174,189 shares), Sell ROIV (160,035 shares), Buy ROIV (1.4M shares), Sell ROIV (1.4M shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 40,310 | $1.4M |
| 2026-04-09 | Immunovant, Inc. (IMVT) | Director | Buy | 174,189 | $0 |
| 2026-04-02 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 160,035 | $4.4M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 1.4M | $5.4M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 1.4M | $38.4M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 1.0M | $3.9M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 1.0M | $27.5M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 587,390 | $2.3M |
| 2026-02-23 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 587,390 | $16.2M |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 64,891 | $1.5M |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 175,380 | $3.9M |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Sell | 110,489 | $0 |
| 2025-08-01 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 1.8M | $0 |
| 2025-08-01 | Roivant Sciences Ltd. (ROIV) | President and Vant Chair | Buy | 11.9M | $0 |
| 2025-04-03 | Immunovant, Inc. (IMVT) | Director | Buy | 199,365 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02